Biochemical Monitoring of the Treatment in Paediatric Patients with Mitochondrial Disease

Overview

Journal J Inherit Metab Dis

Publisher Wiley

Date 1998 Dec 31

PMID 9870209

Citations 8

Authors

R Artuch

M A Vilaseca

M Pineda

Affiliations

Soon will be listed here.

Abstract

Treatment strategies in mitochondrial diseases consist of several drugs that diminish the deleterious effects of the abnormal respiratory chain function, reduce the presence of toxic agents or correct deficiencies in essential cofactors. In this study we evaluated the monitoring of tocopherol, carnitine and ubiquinone concentrations in a group of paediatric patients during a follow-up period of 18 months and the response to treatment of these patients by means of the determination of blood lactate, plasma alanine and oxygen consumption by lymphocytes in relation to the clinical status of the patients. Tocopherol, carnitine and ubiquinone concentrations were easily corrected with therapy. Blood lactate proved the best biochemical tool to assess the response to treatment in paediatric patients. According to our results, improvement or stabilization of the clinical course seems to be more related to the biochemical or molecular defect than to the effectiveness of the treatment.

Citing Articles

An Overview of Mitochondrial Protein Defects in Neuromuscular Diseases.

Marra F, Lunetti P, Curcio R, Lasorsa F, Capobianco L, Porcelli V Biomolecules. 2021; 11(11).

PMID: 34827632 PMC: 8615828. DOI: 10.3390/biom11111633.

Current and Emerging Clinical Treatment in Mitochondrial Disease.

Tinker R, Lim A, Stefanetti R, McFarland R Mol Diagn Ther. 2021; 25(2):181-206.

PMID: 33646563 PMC: 7919238. DOI: 10.1007/s40291-020-00510-6.

Nutritional Interventions for Mitochondrial OXPHOS Deficiencies: Mechanisms and Model Systems.

Kuszak A, Espey M, Falk M, Holmbeck M, Manfredi G, Shadel G Annu Rev Pathol. 2017; 13:163-191.

PMID: 29099651 PMC: 5911915. DOI: 10.1146/annurev-pathol-020117-043644.

Mitochondrial disease patients' perception of dietary supplements' use.

Karaa A, Kriger J, Grier J, Holbert A, Thompson J, Parikh S Mol Genet Metab. 2016; 119(1-2):100-8.

PMID: 27444792 PMC: 5031526. DOI: 10.1016/j.ymgme.2016.07.005.

Nutrition Therapy for Mitochondrial Neurogastrointestinal Encephalopathy with Homozygous Mutation of the TYMP Gene.

Wang J, Chen W, Wang F, Wu D, Qian J, Kang J Clin Nutr Res. 2015; 4(2):132-6.

PMID: 25954734 PMC: 4418417. DOI: 10.7762/cnr.2015.4.2.132.

References

Roe D, Terada N, Millington D . Automated analysis for free and short-chain acylcarnitine in plasma with a centrifugal analyzer. Clin Chem. 1992; 38(11):2215-20. View

Pons R, De Vivo D . Primary and secondary carnitine deficiency syndromes. J Child Neurol. 1995; 10 Suppl 2:S8-24. View

Matthews P, Ford B, Dandurand R, Eidelman D, OConnor D, Sherwin A . Coenzyme Q10 with multiple vitamins is generally ineffective in treatment of mitochondrial disease. Neurology. 1993; 43(5):884-90. DOI: 10.1212/wnl.43.5.884. View

Sengers R, Fischer J, Trijbels J, Ruitenbeek W, STADHOUDERS A, ter Laak H . A mitochondrial myopathy with a defective respiratory chain and carnitine deficiency. Eur J Pediatr. 1983; 140(4):332-7. DOI: 10.1007/BF00442676. View

Campos Y, Huertas R, Lorenzo G, Bautista J, Gutierrez E, Aparicio M . Plasma carnitine insufficiency and effectiveness of L-carnitine therapy in patients with mitochondrial myopathy. Muscle Nerve. 1993; 16(2):150-3. DOI: 10.1002/mus.880160205. View

Moyano D, Vilaseca M, Pineda M, Campistol J, Vernet A, Poo P . Tocopherol in inborn errors of intermediary metabolism. Clin Chim Acta. 1997; 263(2):147-55. DOI: 10.1016/s0009-8981(97)00061-2. View

Bernsen P, Gabreels F, Ruitenbeek W, Sengers R, STADHOUDERS A, Renier W . Successful treatment of pure myopathy, associated with complex I deficiency, with riboflavin and carnitine. Arch Neurol. 1991; 48(3):334-8. DOI: 10.1001/archneur.1991.00530150106028. View

Artuch R, Vilaseca M, Farre C, Ramon F . Determination of lactate, pyruvate, beta-hydroxybutyrate and acetoacetate with a centrifugal analyser. Eur J Clin Chem Clin Biochem. 1995; 33(8):529-33. View

Ichiki T, Tanaka M, Nishikimi M, Suzuki H, Ozawa T, Kobayashi M . Deficiency of subunits of Complex I and mitochondrial encephalomyopathy. Ann Neurol. 1988; 23(3):287-94. DOI: 10.1002/ana.410230312. View

10.

Przyrembel H . Therapy of mitochondrial disorders. J Inherit Metab Dis. 1987; 10 Suppl 1:129-46. DOI: 10.1007/BF01812853. View

11.

Shoffner J, Wallace D . Oxidative phosphorylation diseases and mitochondrial DNA mutations: diagnosis and treatment. Annu Rev Nutr. 1994; 14:535-68. DOI: 10.1146/annurev.nu.14.070194.002535. View

12.

Herbert V . Prooxidant effects of antioxidant vitamins. Introduction. J Nutr. 1996; 126(4 Suppl):1197S-200S. View

13.

MORRIS A, Leonard J . The treatment of congenital lactic acidoses. J Inherit Metab Dis. 1996; 19(4):573-80. DOI: 10.1007/BF01799117. View

14.

Ernster L, Dallner G . Biochemical, physiological and medical aspects of ubiquinone function. Biochim Biophys Acta. 1995; 1271(1):195-204. DOI: 10.1016/0925-4439(95)00028-3. View

15.

Rustin P, Chretien D, Bourgeron T, Gerard B, Rotig A, Saudubray J . Biochemical and molecular investigations in respiratory chain deficiencies. Clin Chim Acta. 1994; 228(1):35-51. DOI: 10.1016/0009-8981(94)90055-8. View

16.

Bakker H, Scholte H, Jeneson J . Vitamin E in a mitochondrial myopathy with proliferating mitochondria. Lancet. 1993; 342(8864):175-6. DOI: 10.1016/0140-6736(93)91379-z. View

17.

Zierz S, von Wersebe O, Bleistein J, Jerusalem F . Exogenous coenzyme Q (coq) fails to increase coq in skeletal muscle of two patients with mitochondrial myopathies. J Neurol Sci. 1990; 95(3):283-90. DOI: 10.1016/0022-510x(90)90075-x. View

18.

Roodhooft A, Van Acker K, Martin J, Ceuterick C, Scholte H . Benign mitochondrial myopathy with deficiency of NADH-CoQ reductase and cytochrome c oxidase. Neuropediatrics. 1986; 17(4):221-6. DOI: 10.1055/s-2008-1052534. View

19.

LOWRY O, ROSEBROUGH N, FARR A, RANDALL R . Protein measurement with the Folin phenol reagent. J Biol Chem. 1951; 193(1):265-75. View

20.

Bendahan D, Desnuelle C, Vanuxem D, Confort-Gouny S, Figarella-Branger D, Pellissier J . 31P NMR spectroscopy and ergometer exercise test as evidence for muscle oxidative performance improvement with coenzyme Q in mitochondrial myopathies. Neurology. 1992; 42(6):1203-8. DOI: 10.1212/wnl.42.6.1203. View